Post-approval studies (Phase 4)Study completedNCT06687499
What this trial is testing
14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection
Who this might be right for
Helicobacter PyloriDrug Resistance, Multiple
National Cheng-Kung University Hospital 46